Dr. Bernard Naughton

Dr. Bernard Naughton

Associate Professor, Pharmacy

Biography

Research Interests Bernard's research focusses on two themes, Pharmaceutical Regulation and Healthcare Management. More specifically he is interested in behaviours, technology, and regulation concerning the global health issue of substandard and falsified medicine. Regarding healthcare innovation, he is interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. His research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as Social Science and Medicine, BMJ Global Health and Lancet Global Health. He has also contributed to the regulatory affair's professional society, where he has authored several book chapters. Background Bernard is an Associate Professor and interdisciplinary researcher at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin where he is also the Director of the MSc in Pharmaceutical Manufacturing Technology. Prior to this appointment, Bernard was a research fellow at the Saïd Business School, and a member of St Antony's College, at the University of Oxford. Bernard holds a PhD in science and technology in medicine which was jointly supervised by the University of Oxford, Saïd Business School and the Institute of Science and Technology at Keele University. Bernard is a clinical pharmacist by training and has over ten years' experience working with large NHS teaching hospitals. Funders Bernards research has been funded by The University of Oxford, the Norwegian Research Council, the Wellcome Trust, and private technology firms. Other Engagements Bernard is an associate editor for the Sage journal The Journal of Medicine Access, and a Visiting Senior Lecturer in the Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London. Bernard has also consulted for charities, education providers, professional and regulatory bodies, and the pharmaceutical industry.

Publications and Further Research Outputs

  • Murphy N., Garvey E., Naughton B.D., Use of design thinking to develop a benchmarking tool to assess documentation procedures in a hospital pharmacy aseptic compounding unit: a case study, European Journal of Hospital Pharmacy, 2025Journal Article, 2025, DOI
  • Naughton B.D., Planned Behavior in the United Kingdom and Ireland Online Medicine Purchasing Context: Mixed Methods Survey Study, JMIR Formative Research, 9, 2025Journal Article, 2025, DOI
  • Naser K., Haq Z., Naughton B.D., The Impact of Climate Change on Health Services in Low- and Middle-Income Countries: A Systematised Review and Thematic Analysis, International Journal of Environmental Research and Public Health, 21, (4), 2024Review, 2024, DOI
  • Melia E., English A., Naughton B.D., The impact of global falsified medicines regulation on healthcare stakeholders in the legitimate pharmaceutical supply chain: a systematic review, Frontiers in Medicine, 11, 2024Review, 2024, DOI
  • Niarchou E, Roberts LH, Naughton BD., What is the impact of antidepressant side effects on medication adherence among adult patients diagnosed with depressive disorder: A systematic review., Journal of psychopharmacology (Oxford, England), 38, (2), 2024, p127-136Journal Article, 2024, DOI
  • Muireann Counihan, Larisa Cervenakova, Dominika Misztela, Maarten Van Baelen, Bernard D. Naughton, Original Research, The Journal of Medicine Access, 2024Journal Article, 2024
  • Counihan M., Cervenakova L., Misztela D., Van Baelen M., D.Naughton B., Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set, Journal of Medicine Access, 8, 2024Journal Article, 2024, DOI
  • Howlett M., Niarchou E., Naughton B.D., The response of the Irish pharmaceutical manufacturing sector to the COVID-19 pandemic with a focus on Lean and JIT, Journal of Medicine Access, 8, 2024Journal Article, 2024, DOI
  • Gill M.J., Naughton B.D., Field M., Shaw S.E., Perceptions of impure innovation: Health professionals" experiences and management of stigmatization when working as digital innovators, Social Science and Medicine, 360, 2024Journal Article, 2024, DOI
  • BD Naughton, MJ Gill, M Field, S Shaw, Impure innovation: Intra-professional stigmatization of radical ideas, 39th EGOS Colloquium, Cagliari 2023, Cagliari, Italy, 2023Oral Presentation, 2023
  • Bernard Naughton, Responsible impact and the reinforcement of responsible innovation in the public sector ecosystem: cases of digital health innovation, Journal of Responsible Innovation , 2023Journal Article, 2023
  • Muireann Counihan, Larisa Cervenakova, Dominika Misztela, Maarten Van Baelen and Bernard D. Naughton, Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review, The Journal of Medicine Access, 2023, p10.1177/27550834231197315Journal Article, 2023
  • Bernard David Naughton, Ebru Akgul, Medicine quality in high-income countries: The obstacles to comparative prevalence studies, Medicine Access @ Point of Care, 5, 2021, p239920262110522Journal Article, 2021, DOI
  • Transformation2: leading a megaproject turnaround in, Edward Elgar Publishing, 2021, pp62-83 , [Naughton, Bernard, Maylor, Harvey]Book Chapter, 2021, DOI
  • McManus D, Naughton BD., A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality., BMJ global health, 5, (8), 2020Journal Article, 2020, DOI
  • Newton, Paul N, Bond, Katherine C, Adeyeye, Moji, Antignac, Marie, Ashenef, Ayenew, Awab, Ghulam Rahim, Babar, Zaheer-Ud-Din, Bannenberg, Wilbert J, Bond, Katherine C, Bower, Jason, Breman, Joel, Brock, Aleisha, Caillet, Céline, Coyne, Philip, Day, Nicholas, Deats, Michael, Douidy, Kawtar, Doyle, Kim, Dujardin, Catherine, Ejekam, Chioma S, Fernández, Facundo, Freifeld, Clark, Gill, Marie, Guerin, Philippe J, Harigwo, Georgina, Heide, Lutz, Horby, Peter, Kaur, Harparkash, Kayumba, Pierre Claver, Kazuko, Kimura, Kelly, Cassandra, Khuluza, Felix, Kigera, Stephen, Lalani, Mirza, Lamy, Marie, Lieberman, Marya, Lumpkin, Murray, Mackey, Tim, Naughton, Bernard, Newton, Paul N, Nguyen, Philip, Olliaro, Piero, Ozawa, Sachiko, Patel, Anushka, Phanouvong, Souly, Pisani, Elizabeth, Pyzik, Oksana, Rägo, Lembit, Rahman, Mohammad Sofiqur, Ranjit, Eurek, Ravinetto, Raffaella, Richmond, David, Singh-Phulgenda, Sauman, Venema, Jaap, Vogt, Andrea, White, Nicholas, Wirtz, Veronika J, Zaman, Muhammad, COVID-19 and risks to the supply and quality of tests, drugs, and vaccines, The Lancet Global Health, 8, (6), 2020, pe754-e755Journal Article, 2020, DOI
  • Naughton BD., Medicine authentication technology: a quantitative study of incorrect quarantine, average response times and offline issues in a hospital setting., BMJ Open, 9, (2), 2019, pe026619Journal Article, 2019, DOI
  • Newton PN, Bond KC, Oxford Statement signatories., Global access to quality-assured medical products: the Oxford Statement and call to action., The Lancet. Global health, 7, (12), 2019, pe1609-e1611Journal Article, 2019, DOI
  • Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare in, editor(s)Tatiana Iakovleva, Elin M Oftedal, John Bessant , Responsible Innovation in Digital Health, Cheltenham UK, Edward Elgar Publishing, 2019, ppdoi.org/10.4337/978178 , [Bernard Naughton, Lene Foss]Book Chapter, 2019
  • Pathways for Prosperity Commission, The future of falsified and substandard medicine detection: digital methods to track and authenticate pharmaceutical products, 2018Report, 2018
  • Merks P, Swieczkowski D, Byliniak M, Drozd M, Krupa K, Jaguszewski M, Brindley DA, Naughton BD., The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists., Eur J Hosp Pharm, 25, (1), 2018, p10-15Journal Article, 2018, DOI
  • Naughton B, Roberts L, Dopson S, Brindley D, Chapman S., Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care., BMJ Open, 7, (5), 2017, pe013838Journal Article, 2017, DOI
  • Naughton, Bernard D., The EU Falsified Medicines Directive: Key Implications for Dispensers, Medicine Access @ Point of Care, 1, 2017, pmaapoc.0000024Journal Article, 2017, DOI
  • International Counterfeit Medicine Regulation in, Fundamentals of International Regulatory Affairs, Regulatory Affairs' Professional Society, 2017, [Naughton B, Koshkouei M, Brindley D et al]Book Chapter, 2017
  • Traceability and Supply Chain in, Fundamentals of US Regulatory Affairs, 2017, [Naughton B, Koshkouei M, Brindley D]Book Chapter, 2017
  • Bernard Naughton (selected chapters), The Oxford Handbook of Clinical Pharmacy, Oxford University Press, 2017Book, 2017, DOI
  • Naughton BD, Smith JA, Brindley DA., Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety., Eur J Hosp Pharm, 23, (2), 2016, p118-120Journal Article, 2016, DOI
  • Naughton B, Roberts L, Dopson S, Chapman S, Brindley D., Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study., BMJ Open, 6, (12), 2016, pe013837Journal Article, 2016, DOI
  • DA, Pettitt, S, Raza, The Limitations of QALY: A Literature Review, Journal of Stem Cell Research & Therapy, 06, (04), 2016Journal Article, 2016, DOI
  • Naughton, BD, Vadher, B, Smith, J, Smith, G, Chapman, SR, Dopson, S, Brindley, DA, EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review, Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 12, (3-4), 2015, p95-101Journal Article, 2015, DOI
  • European Union Falsified Medicines Directive: Requirements and Implications for Multi-Stakeholder Healthcare Delivery in, Fundamentals of EU Regulatory Affairs, 2015, [Smith, J., Naughton, B., and Kramm, A]Book Chapter, 2015
  • Stephen R Chapman, Nicholas Thayer, Bernard Naughton, UK/USA Differences in Marketing Claim, Pharmacoepidemiology and Drug Safety, 2010Journal Article, 2010, URL

Research Expertise

My research focusses on two themes, 1. Medicine Quality and 2. Healthcare Innovation. More specifically he is interested in estimating the problem as well as behaviour, technology, and regulation concerning substandard and falsified medicine. Regarding healthcare innovation, I am interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. My research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. I have also contributed to the regulatory affair's professional society, where I have authored several book chapters.

Recognition

  • Royal Pharmaceutical Society of Great Britain Current
  • Academy of Management Current
  • Regulatory Affairs Professional Society Current